BRIEF published on 12/04/2025 at 06:35, 5 months 8 days ago Formycon et MS Pharma collaborent pour le biosimilaire de Keytruda® au Moyen-Orient et en Afrique du Nord MS Pharma Keytruda® FYB206 Accord Sur Les Biosimilaires Marché MENA Partenariat Formycon
BRIEF published on 12/04/2025 at 06:35, 5 months 8 days ago Formycon and MS Pharma Collaborate for Keytruda® Biosimilar in MENA MS Pharma Biosimilar Agreement Keytruda® FYB206 MENA Market Formycon Partnership
PRESS RELEASE published on 12/04/2025 at 06:30, 5 months 8 days ago Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region Formycon AG and MS Pharma enter exclusive partnership to commercialize Keytruda biosimilar FYB206 in MENA region, aiming to enhance cancer drug access MENA Region MS Pharma Biosimilar Formycon Keytruda
BRIEF published on 11/24/2025 at 06:35, 5 months 18 days ago Formycon s'associe à NTC pour la commercialisation de biosimilaires en Italie Formycon AG Ophtalmologie FYB203/Baiama® Partenariats En Matière De Biosimilaires Marché Pharmaceutique Italien
BRIEF published on 11/24/2025 at 06:35, 5 months 18 days ago Formycon Partners with NTC for Biosimilar Commercialization in Italy Formycon AG Ophthalmology Biosimilar Partnerships Italy Pharmaceutical Market FYB203/Baiama®
PRESS RELEASE published on 11/24/2025 at 06:30, 5 months 18 days ago NTC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/Baiama® in Italy Formycon AG partners with NTC for Eylea biosimilar commercialization in Italy. Agreement includes royalties and supply chain organization Italy Formycon AG Commercialization Eylea Biosimilar NTC
BRIEF published on 11/20/2025 at 17:05, 5 months 21 days ago First Berlin Reaffirms Buy Rating for Formycon AG BUY Rating Formycon AG Revenue Guidance Dupixent Keytruda Biosimilar
BRIEF published on 11/20/2025 at 17:05, 5 months 21 days ago First Berlin réaffirme sa recommandation d'achat sur Formycon AG Formycon AG Dupixent Évaluation D'achat Prévisions De Recettes Biosimilaire De Keytruda
PRESS RELEASE published on 11/20/2025 at 17:00, 5 months 21 days ago Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Buy recommendation on Formycon AG (DE000A1EWVY8) to EUR 53 target price post Q3 results surpassing expectations and upcoming FYB206 study endpoint results First Berlin Equity Research Buy Recommendation Formycon AG FYB206 EUR 53 Target Price
BRIEF published on 11/20/2025 at 06:35, 5 months 22 days ago Ranibizumab Biosimilar Epruvy® Launched in Germany Formycon AG Ranibizumab Biosimilar Germany Launch Ophthalmic Care
Published on 05/12/2026 at 06:00, 1 hour 59 minutes ago NOA Lithium Announces Strategic Collaboration with Hidrotec to Support NOA Projects
Published on 05/12/2026 at 04:20, 3 hours 39 minutes ago AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
Published on 05/12/2026 at 03:05, 4 hours 54 minutes ago UraniumX Reports Tragic Incident at Its Zoo Bay Property
Published on 05/12/2026 at 00:00, 7 hours 59 minutes ago PPX Mining Provides Update on Start-up of the Process Plant
Published on 05/12/2026 at 00:00, 7 hours 59 minutes ago Redwood AI Included in Innovate BC Investor Showcase: BC's Top 25 Investible Companies Event
Published on 05/12/2026 at 07:45, 14 minutes ago Delignit AG has made a positive start to the 2026 financial year and confirmed its guidance
Published on 05/12/2026 at 07:45, 14 minutes ago Aumann with progressing diversification and solid profitability in the first quarter of 2026
Published on 05/12/2026 at 07:45, 14 minutes ago Eckert & Ziegler with a Successful Start to the Year. 2026 Forecast Confirmed.
Published on 05/12/2026 at 07:37, 21 minutes ago Medios reports further revenue growth in the first quarter of 2026 and confirms guidance for the full year
Published on 05/12/2026 at 07:35, 24 minutes ago Carl Zeiss Meditec reports lower earnings in the first half of 2025/26 – Comprehensive package of measures planned
Published on 05/11/2026 at 19:02, 12 hours 56 minutes ago 260511 BENETEAU Transactions sur actions propres
